Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Arnold Altman"'
1
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
Autor: Sima Jeha, Bassem Razzouk, Michael Rytting, Susan Rheingold, Edythe Albano, Richard Kadota, Lori Luchtman-Jones, Lisa Bomgaars, Paul Gaynon, Stewart Goldman, Kim Ritchey, Robert Arceci, Arnold Altman, Kimo Stine, Laurel Steinherz, Peter Steinherz
Publikováno v: Journal of Clinical Oncology. 27:4392-4397
Purpose To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML). Patients and Methods A phase II, open-label, multicenter study was conducted with single-agent clofarabine in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe0c6cd9bcddb160f161989241fd7eb
https://doi.org/10.1200/jco.2008.18.8706
Zobrazit plný text záznamu
2
Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
Autor: Sima Jeha, Paul S. Gaynon, Bassem I. Razzouk, Janet Franklin, Richard Kadota, Violet Shen, Lori Luchtman-Jones, Michael Rytting, Lisa R. Bomgaars, Susan Rheingold, Kim Ritchey, Edythe Albano, Robert J. Arceci, Stewart Goldman, Timothy Griffin, Arnold Altman, Bruce Gordon, Laurel Steinherz, Steven Weitman, Peter Steinherz
Publikováno v: Journal of Clinical Oncology. 24:1917-1923
Purpose To evaluate the efficacy and safety of clofarabine, a novel deoxyadenosine analog, in pediatric patients with refractory or relapsed acute lymphoblastic leukemia (ALL). Patients and Methods In a phase II, open-label, multicenter study, 61 ped
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000874592f4b52aa9574002bf4de2091
https://doi.org/10.1200/jco.2005.03.8554
Zobrazit plný text záznamu
6
A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemia
Autor: Cristina E. Marshall-Taylor, Arnold Altman, Matthew T. Hurford, Jackie Z. Zhou, William N. Rezuke, Lawrence M. Silverman, Sandy Vicki, Gregory J. Tsongalis
Publikováno v: Clinica chimica acta; international journal of clinical chemistry. 321(1-2)
Background: Mutations in the erythroid-specific 5-aminolevulinate-synthase gene (ALAS2) have been identified in many cases of X-linked sideroblastic anemia (XLSA). Methods: A polymerase chain reaction-mediated restriction fragment length polymorphism
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd35b70b57f419b0ba9b44c9237177e
https://pubmed.ncbi.nlm.nih.gov/12031592
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje